arrow_back Civic Audit
Share share

New Rules for Reporting Suspicious Drug Orders for Public Safety

This law establishes clear new rules for companies dealing with controlled substances. They are now required to more thoroughly investigate suspicious orders and report them to the relevant authorities, aiming to curb illegal drug trafficking and enhance public safety.
Key points
Companies must now more thoroughly investigate any suspicious order for controlled substances.
If a company cannot resolve the suspicious circumstances, it must decline to fill the order.
All suspicious orders must be reported to the Drug Enforcement Administration (DEA).
Detailed regulations will be developed within a year to specify what constitutes a suspicious order.
article Official text account_balance Process page notifications_active Track this Bill
Status: Expired
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_768
Sponsor: Rep. McKinley, David B. [R-WV-1]
Process start date: 2021-02-03
System Note: Lustra is free, open-source civic infrastructure. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Block, Report, And Suspend Suspicious Shipments Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_768.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-02-03.

What are the main provisions?

Key points include:

  • Companies must now more thoroughly investigate any suspicious order for controlled substances.
  • If a company cannot resolve the suspicious circumstances, it must decline to fill the order.
  • All suspicious orders must be reported to the Drug Enforcement Administration (DEA).
  • Detailed regulations will be developed within a year to specify what constitutes a suspicious order.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McKinley, David B. [R-WV-1].

What is the latest detailed status?

The latest detailed status is: Pursuant to section 6 of H. Res. 380, and the motion offered by Mr. Hoyer, the following bills passed under suspension of the rules: H.R. 297; H.R. 433; H.R. 478; H.R. 586; H.R. 721, as amended; H.R. 768; H.R. 810; H.R. 1205; H.R. 1260, as amended; H.R. 1324; H.R. 1448, as amended; H.R. 1475, as amended; H.R. 1480, as amended; H.R. 2862, as amended; H.R. 2955; and H.R. 2981. (consideration: CR H2235-2246; text: CR H2237-2238)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Security Courts and Law